Dornier MedTech Introduces the New Medilas D UroBeam Laser

Stuttgart, Germany – September 24, 2008 – Dornier MedTech introduces the new high powered Medilas D UroBeam laser at the Kongress der Deutschen Gesellschaft fur Urologie (DGU). In addition to Dornier’s reputable diode technology, the Medilas D UroBeam offers a 940nm wavelength and 250 watts of power. This state-of-the-art system creates the model solution for the minimally invasive tissue ablation treatment of Benign Prostatic Hyperplasia (BPH) by improving both urinary flow and symptoms.

“We are excited about the introduction of the UroBeam into the Medilas family of lasers. Dornier believes that the higher power offers the physician greater treatment flexibility and creates the optimal solution for effectively treating BPH.  The absorption characteristics targeting both water and hemoglobin optimize this approach and remove the limitations experienced by other devices.  We feel this is a significant complement to our existing portfolio of urology products allowing us to expand our addressable market,” commented Michael Lerch, General Manager of Dornier MedTech Europe.

In addition, The Medilas D UroBeam laser includes the proprietary Lightguide Protection System (LPS), which disables the laser in the event of excessive heat at the fiber tip. In addition, the system supports a special fibertom™ mode that keeps the tip temperature constant by automatically controlling the laser output power.

Dornier MedTech is an innovative market leader in both the urology and medical-aesthetic laser markets. As the inventor of lithotripsy and pioneer of a variety of medical-aesthetic lasers, Dornier continues to develop advanced medical solutions.  Dornier also offers urology imaging systems and orthopedic shock wave devices.  As a global company, Dornier has operating units and service partners throughout the world.  Dornier MedTech (www.dornier.com) is a privately held company headquartered in Munich, Germany.  For more information please contact at 1-770-426-1315.